People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rakuten Medical, Inc. | — | Biotechnology | Series D+ | $787.8M | $17.7M | 2024 |
Mazen Darwazah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mazen Darwazah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Chao | 1 | 11 |
| Hiroshi Mikitani | 1 | 3 |
| Carlos Garcia | 1 | 3 |
| Dana Johnson | 1 | 3 |
| Merrill Biel | 1 | 2 |
| Miguel Garcia-Guzman | 1 | 2 |
| Nitin Nohria | 1 | 2 |
| Minami Maeda | 1 | 1 |
| Toshiaki Suzuki | 1 | 1 |
| Kentaro Hyakuno | 1 | 1 |
| Hiroshi Takasawa | 1 | 1 |
| Takashi Toraishi | 1 | 1 |
| Agatha Martindale | 1 | 1 |
| Mazen Darwazeh | 1 | 1 |
| Ann McGuire | 1 | 1 |
| Brenton Keath | 1 | 1 |
| Hiroshi Mori | 1 | 1 |
| Scott Salka | 1 | 1 |
| Abhijit Bhatia | 1 | 1 |
| Tiffany Piecewicz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.